FDA moves to fast-track three psychedelic drugs for review
A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC's Anne Thompson reports.
Original Source
Read the full article at Nbcnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.